Scopus BioPharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCPS research report →
About the company
Scopus BioPharma Inc. is a biopharmaceutical company in the clinical development phase, dedicated to pioneering innovative treatments for serious diseases. Its core development programs are concentrated on immuno-oncology gene therapies designed to combat various forms of cancer.
- CEO
- Alan D. Horsager
- IPO
- 2020
- Employees
- 13
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $21.04K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- 0.01
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 911.69%
- ROIC
- 164.39%
- Revenue
- $0 · 0.00%
- Net Income
- $-11,609,827 · 58.13%
- EPS
- $-0.55 · 65.84%
- Op Income
- $-11,714,877
- FCF YoY
- 28.87%
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -2.01
- Avg Volume
- 1.80K
Get TickerSpark's AI analysis on SCPS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 23, 21 | Greenspan Ira Scott | other | 3,000,000 |
| Nov 23, 21 | Lamstein Joshua R | other | 3,000,000 |
| Jun 1, 21 | Hopper Paul | other | 6,333 |
| Dec 15, 20 | Hopper Paul | other | 0 |
| Oct 1, 21 | Hopper Paul | other | 0 |
| Oct 1, 21 | Hopper Paul | other | 0 |
| Dec 15, 20 | Hopper Paul | other | 0 |
| Aug 27, 21 | Greenspan Ira Scott | buy | 110 |
| Aug 27, 21 | Greenspan Ira Scott | buy | 790 |
| Aug 27, 21 | Lamstein Joshua R | buy | 200 |
Our SCPS coverage
Recent articles, reports, and earnings notes.
No research on SCPS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SCPS report →Similar companies
Peers in the same neighborhood.